EARLY ACCESS & PILOT PROGRAM
Pilot continuous, cuffless blood pressure monitoring with CureTech
For RPM companies, clinics, health systems and healthcare organizations ready to evaluate the next generation of BP monitoring.
In development · validation in progress · not yet available for sale
Who we are partnering with
RPM companies & platforms
Evaluate how continuous BP data could fit your existing RPM workflows, dashboards and APIs.
Clinics & physician groups
Explore how overnight, daily-activity and exercise BP trends could support hypertension care.
Health systems & organizations
Help define the evidence, workflow and reimbursement requirements needed for adoption.
What pilot partners get
Early evaluation access
Hands-on evaluation as units become available.
A voice in development
Shape features, integrations and reporting.
Priority consideration
Early consideration for planned pilot programs.
Direct team access
Work with our clinical and engineering team.
How it works
1
Register interest
Tell us about your organization and goals. No payment, no commitment.
2
Discovery call
We discuss your workflows, requirements and timeline.
3
Scope a pilot
If there is a fit, we outline a pilot, starting with a non-binding letter of intent.
Register your interest
Tell us about your organization and what you would like to explore. Non-binding. No payment is required.
CureTech’s technology is under development and is not yet cleared, approved, authorized, or otherwise commercially authorized for sale as a medical device in any jurisdiction. Commercial availability will depend on completing the applicable validation and regulatory processes and obtaining any required regulatory authorizations or certifications. For example, this may include an applicable FDA pathway in the United States and CE marking in the European Union. The technology is not intended to diagnose, treat, cure, or prevent any disease or condition at this stage.